Most Kids Newly Diagnosed With ADHD Aren’t Getting Best Care
6:03 PM CDT.
By Dennis Thompson HealthDay Reporter Read article
- FDA Eases Access to Cheaper Over-the-Counter Hearing Aids
- U.S. Pediatricians, Psychiatrists Declare ‘Emergency’ in Child Mental Health
- AHA News: A Heart Patient as a Child, He’s Now a Resident Caring for Heart Patients
- Laser Therapy Promises to ‘Rejuvenate’ Vaginal Tissue. A New Study Finds Otherwise
JOURNAL UPDATE
Women Working as Family Docs Report High Career Satisfaction Overall
10:45 PM CDT.Women are less satisfied with certain aspects of their career, including pay, personal time,…
- USPSTF: Evidence Lacking for Screening for Eating Disorders
- Maternal Cholesterol in Pregnancy Tied to AMI Severity in Adult Offspring
- Varenicline Combo, Extension No Better for Quitting Smoking
MONTHLY JOURNAL SUMMARY
September 2020 Briefing - Pharmacy
October 01, 2020. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Immunotherapy with Checkpoint Inhibitors in Triple Negative Breast Cancer (TNBC)
Karima Oualla, MD.
Dr. Karima Oualla discusses recent advances on the use of checkpoint inhibitors in the treatment of triple negative breast cancer (TNBC). Dr. Oualla is an International expert in breast cancer and is the primary author of the manuscript entitled "Novel therapeutic strategies in the treatment of triple-negative…
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
MEDICAL FOCUS
Acute dyspnea (shortness of breath)
By Tamer M. Fouad, M.D.Dyspnea (shortness of breath) is a term used to characterize a subjective experience of breathing discomfort that is comprised of qualitatively distinct…
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By namabcAs I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…
ANNOUNCEMENTS
Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.
